The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer

Edgard Graner, Dan Tang, Sabrina Rossi, Antonella Baron, Toshiro Migita, Lisa J. Weinstein, Mirna Lechpammer, Dieter Huesken, Johann Zimmermann, Sabina Signoretti, Massimo Loda

Research output: Contribution to journalArticle

218 Citations (Scopus)

Abstract

Cellular levels of key regulatory proteins are controlled via ubiquitination and subsequent degradation. Deubiquitinating enzymes or isopeptidases can potentially prevent targeted destruction of protein substrates through deubiquitination prior to proteasomal degradation. However, only one deubiquitinating enzyme to date has been matched to a specific substrate in mammalian cells and shown to functionally modify it. Here we show that the isopeptidase USP2a (ubiquitin-specific protease-2a) interacts with and stabilizes fatty acid synthase (FAS), which is often overexpressed in biologically aggressive human tumors. Further, USP2a is androgen-regulated and overexpressed in prostate cancer, and its functional inactivation results in decreased FAS protein and enhanced apoptosis. Thus, the isopeptidase USP2a plays a critical role in prostate cancer cell survival through FAS stabilization and represents a therapeutic target in prostate cancer.

Original languageEnglish (US)
Pages (from-to)253-261
Number of pages9
JournalCancer Cell
Volume5
Issue number3
DOIs
StatePublished - Mar 2004
Externally publishedYes

Fingerprint

Ubiquitin-Specific Proteases
Fatty Acid Synthases
Prostatic Neoplasms
Proteins
Ubiquitination
Androgens
Cell Survival
Apoptosis
isopeptidase
Neoplasms
Deubiquitinating Enzymes
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Oncology

Cite this

Graner, E., Tang, D., Rossi, S., Baron, A., Migita, T., Weinstein, L. J., ... Loda, M. (2004). The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer. Cancer Cell, 5(3), 253-261. https://doi.org/10.1016/S1535-6108(04)00055-8

The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer. / Graner, Edgard; Tang, Dan; Rossi, Sabrina; Baron, Antonella; Migita, Toshiro; Weinstein, Lisa J.; Lechpammer, Mirna; Huesken, Dieter; Zimmermann, Johann; Signoretti, Sabina; Loda, Massimo.

In: Cancer Cell, Vol. 5, No. 3, 03.2004, p. 253-261.

Research output: Contribution to journalArticle

Graner, E, Tang, D, Rossi, S, Baron, A, Migita, T, Weinstein, LJ, Lechpammer, M, Huesken, D, Zimmermann, J, Signoretti, S & Loda, M 2004, 'The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer', Cancer Cell, vol. 5, no. 3, pp. 253-261. https://doi.org/10.1016/S1535-6108(04)00055-8
Graner, Edgard ; Tang, Dan ; Rossi, Sabrina ; Baron, Antonella ; Migita, Toshiro ; Weinstein, Lisa J. ; Lechpammer, Mirna ; Huesken, Dieter ; Zimmermann, Johann ; Signoretti, Sabina ; Loda, Massimo. / The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer. In: Cancer Cell. 2004 ; Vol. 5, No. 3. pp. 253-261.
@article{28186f3d4034431daeb0bbb5c0837c5f,
title = "The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer",
abstract = "Cellular levels of key regulatory proteins are controlled via ubiquitination and subsequent degradation. Deubiquitinating enzymes or isopeptidases can potentially prevent targeted destruction of protein substrates through deubiquitination prior to proteasomal degradation. However, only one deubiquitinating enzyme to date has been matched to a specific substrate in mammalian cells and shown to functionally modify it. Here we show that the isopeptidase USP2a (ubiquitin-specific protease-2a) interacts with and stabilizes fatty acid synthase (FAS), which is often overexpressed in biologically aggressive human tumors. Further, USP2a is androgen-regulated and overexpressed in prostate cancer, and its functional inactivation results in decreased FAS protein and enhanced apoptosis. Thus, the isopeptidase USP2a plays a critical role in prostate cancer cell survival through FAS stabilization and represents a therapeutic target in prostate cancer.",
author = "Edgard Graner and Dan Tang and Sabrina Rossi and Antonella Baron and Toshiro Migita and Weinstein, {Lisa J.} and Mirna Lechpammer and Dieter Huesken and Johann Zimmermann and Sabina Signoretti and Massimo Loda",
year = "2004",
month = "3",
doi = "10.1016/S1535-6108(04)00055-8",
language = "English (US)",
volume = "5",
pages = "253--261",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "3",

}

TY - JOUR

T1 - The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer

AU - Graner, Edgard

AU - Tang, Dan

AU - Rossi, Sabrina

AU - Baron, Antonella

AU - Migita, Toshiro

AU - Weinstein, Lisa J.

AU - Lechpammer, Mirna

AU - Huesken, Dieter

AU - Zimmermann, Johann

AU - Signoretti, Sabina

AU - Loda, Massimo

PY - 2004/3

Y1 - 2004/3

N2 - Cellular levels of key regulatory proteins are controlled via ubiquitination and subsequent degradation. Deubiquitinating enzymes or isopeptidases can potentially prevent targeted destruction of protein substrates through deubiquitination prior to proteasomal degradation. However, only one deubiquitinating enzyme to date has been matched to a specific substrate in mammalian cells and shown to functionally modify it. Here we show that the isopeptidase USP2a (ubiquitin-specific protease-2a) interacts with and stabilizes fatty acid synthase (FAS), which is often overexpressed in biologically aggressive human tumors. Further, USP2a is androgen-regulated and overexpressed in prostate cancer, and its functional inactivation results in decreased FAS protein and enhanced apoptosis. Thus, the isopeptidase USP2a plays a critical role in prostate cancer cell survival through FAS stabilization and represents a therapeutic target in prostate cancer.

AB - Cellular levels of key regulatory proteins are controlled via ubiquitination and subsequent degradation. Deubiquitinating enzymes or isopeptidases can potentially prevent targeted destruction of protein substrates through deubiquitination prior to proteasomal degradation. However, only one deubiquitinating enzyme to date has been matched to a specific substrate in mammalian cells and shown to functionally modify it. Here we show that the isopeptidase USP2a (ubiquitin-specific protease-2a) interacts with and stabilizes fatty acid synthase (FAS), which is often overexpressed in biologically aggressive human tumors. Further, USP2a is androgen-regulated and overexpressed in prostate cancer, and its functional inactivation results in decreased FAS protein and enhanced apoptosis. Thus, the isopeptidase USP2a plays a critical role in prostate cancer cell survival through FAS stabilization and represents a therapeutic target in prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=12144286902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12144286902&partnerID=8YFLogxK

U2 - 10.1016/S1535-6108(04)00055-8

DO - 10.1016/S1535-6108(04)00055-8

M3 - Article

C2 - 15050917

AN - SCOPUS:12144286902

VL - 5

SP - 253

EP - 261

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 3

ER -